JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
679 results found
Results
Q1 2020 Results Presentation
Investors
Presentation
Q1 2021 Results Presentation
14/05/21
Investors
Results
Q1 2021 Results Presentation
Investors
Presentation
Q1 2022 Results Presentation
06/05/22
Investors
Results
Q1 2022 Results Presentation
Investors
Presentation
Q1 2023 Results Presentation
09/05/23
Investors
Results
Q1 2023 Results Presentation
Investors
Results
Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance
Investors
Press releases
Q1 Revenues and Adjusted EBITDA in line with the high range of the FY’24 Guidance
Price sensitive10/05/24 - 15:21
Investors
Press releases
Q1’23 REVENUES CONFIRM GUIDANCE FOR FISCAL YEAR 2023
Price sensitive09/05/23 - 11:56
Investors
Presentation
Q3 2008 Results Presentation
13/11/08
Investors
Presentation
Q3 2009 Results Presentation
30/10/09
Investors
Presentation
Q3 2010 Results Presentation
05/11/10
Investors
Presentation
Q3 2012 Results Presentation
07/11/12
Investors
Presentation
Q3 2013 Results Presentation
08/11/13
Investors
Presentation
Q3 2014 Results Presentation
14/11/14
Investors
Presentation
Q3 2015 Results Presentation
11/11/15
Investors
Presentation
Q4 2008 Results Presentation
13/02/09
Investors
Presentation
Q4 2009 Results Presentation
12/02/10
Investors
Presentation
Q4 2010 Results Presentation
14/02/11
Investors
Press releases
QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems
08/01/18 - 9:00
Investors
Press releases
QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems
08/01/18 - 9:00
Investors
Coverage
RBC
Investors
Press releases
Record free cash flow generation along with growth in revenues and profitability for DiaSorin in the first 9 months of 2019
06/11/19 - 13:00
Investors
Press releases
Registration and publication the minutes of shareholders' meeting. Withdrawal right.
03/03/25 - 21:19
Investors
Press releases
Resignation of a Strategic Executive of the Company
29/11/17 - 19:30
Investors
Press releases
Revenue growth and strong profitability in the first 9 months of 2022 - Full year 2022 Guidance revised upwards
Price sensitive27/10/22 - 13:44
Investors
Press releases
REVENUE GROWTH, STRONG PROFITABILITY AND ROBUST CASH FLOW GENERATION IN 2022. PROPOSED ORDINARY DIVIDEND OF €1.10 PER SHARE
Price sensitive27/03/23 - 13:35
Investors
Press releases
Revenues at constant perimeter of consolidation and ex-Covid up 5% at CER in Q2. FY 2023 Guidance Confirmed
Price sensitive27/07/23 - 13:18
Investors
Press releases
Revenues, Profitability and Cash Flow Generation hit record highs in 2020
Price sensitive11/03/21 - 15:31
Investors
Press releases
Sale of Flow Cytometry and Imaging business from DiaSorin to Cytek® Biosciences completed
28/02/23 - 16:06
Investors
Press releases
Shareholders' meeting approves FY Results 2012
22/04/13 - 2:00
Investors
Press releases
Shareholders' meeting approves FY Results 2013
23/04/14 - 2:00
Investors
Press releases
Shareholders' meeting approves FY Results 2014
22/04/15 - 2:00
Investors
Press releases
Start up of the treasury shares buy-back plan
17/06/20 - 16:09
Investors
Press releases
Start up of the treasury shares buy-back plan
30/07/21 - 18:43
Investors
Press releases
Start up treasury shares buy-back plan
04/04/18 - 20:00
Investors
Press releases
Start up treasury shares buy-back plan
03/05/18 - 20:15
Investors
Press releases
Start up treasury shares buy-back plan
12/05/16 - 2:00
Investors
Coverage
STIFEL
Investors
Press releases
Stock options exercised by key managers
16/09/10 - 2:00
Investors
Press releases
Strong growth in revenues and cash flow generation in Q1 2022 - Full Year 2022 Guidance revised upwards
Price sensitive06/05/22 - 16:45
Investors
Press releases
Strong revenues growth in the First Half of 2022 - Full Year 2022 Guidance on both Revenues and Profitability revised upwards
Price sensitive03/08/22 - 12:26
Investors
Press releases
Suspension of the effectiveness of the disqualifying accessory administrative sanction imposed by CONSOB to the Chief Executive Officer Mr. Carlo Rosa
Price sensitive03/07/23 - 11:48
Investors
Presentation
Test the future - Investor Day
11/06/19
Investors
Press releases
The Board of Directors approves results for H1'16
04/08/16 - 2:00
Investors
Press releases
The Board of Directors approves the 2015-2017 plan that will be presented at the Investor Day
22/04/15 - 2:00
Investors
Press releases
The Board of Directors approves the Q3'13 Results
08/11/13 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'13
06/03/14 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'14
03/03/15 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'15
09/03/16 - 1:00
Investors
Press releases
The Board of Directors approves the results for FY'16
08/03/17 - 15:30
Investors
Press releases
The Board of Directors approves the results for H1'14
01/08/14 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'13
10/05/13 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'14
09/05/14 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'15
12/05/15 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q1'16
09/05/16 - 2:00
Investors
Press releases
The Board of Directors approves the results for Q3'14
14/11/14 - 1:00
Investors
Press releases
The Board of Directors approves the results for Q3'15
11/11/15 - 1:00
Investors
Press releases
The Board of Directors approves the results for the first half of 2018
02/08/18 - 12:45
Investors
Press releases
The Board of Directors approves the results for the FY '12
30/01/13 - 1:00
Investors
Press releases
The Board of Directors approves the results for the H1 '13
01/08/13 - 2:00
Investors
Results
The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share
Investors
Press releases
The Board of Directors of Diasorin SpA approves FY2023 Results; proposed ordinary dividend of € 1.15 per share
Price sensitive15/03/24 - 13:35
Investors
Press releases
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share
Price sensitive14/03/25 - 16:29
Investors
Press releases
The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018
08/05/18 - 14:30
Investors
Press releases
The Extraordinary Meeting of Shareholders approves the enhancement of the increased voting rights mechanism
28/02/25 - 11:49
Investors
Press releases
The Extraordinary Shareholders' Meeting of DiaSorin authorizes the convertibility of the equity-linked bond and the share capital increase
04/10/21 - 12:27
Investors
Press releases
The LIAISON® SARS-COV-2 S1S2 IgG test is the first to receive the approval from Health Canada
18/05/20 - 11:28
Investors
Press releases
The LIAISON® SARS-COV-2 S1/S2 IgG test received the approval for the commercialization in Brazil from ANVISA
03/06/20 - 14:16
Investors
Press releases
The Ordinary Shareholders' meeting approves the 2010 statutory financial statements and the dividend distribution
28/04/11 - 2:00
Investors
Press releases
The Shareholders’ meeting of Luminex Corporation approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin
21/06/21 - 18:49
Investors
Press releases
The Sonic Healthcare Group chooses DiaSorin
17/01/11 - 1:00
Investors
Press releases
Third Quarter results confirm guidance for Fiscal Year 2023
Price sensitive03/11/23 - 15:51
Investors
Coverage
UBS
Investors
Press releases
Update 2022 Annual Calendar of Corporate Events
06/05/22 - 17:33
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
07/02/23 - 12:01
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
27/03/23 - 15:52
Investors
Press releases
Update 2023 Annual Calendar of Corporate Events
27/07/23 - 14:27
Investors
Press releases
Update Annual Calendar of Corporate Events 2019
30/04/19 - 12:28
Investors
Press releases
Update Annual Calendar of Corporate Events 2020
26/03/20 - 18:14
Investors
Press releases
Update Annual Calendar of Corporate Events 2020
16/09/20 - 14:30
Investors
Press releases
Update annual calendar of corporate events 2022
08/04/22 - 9:53
Investors
Press releases
Voluntarily removal from the STAR segment
11/07/11 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
06/04/18 - 19:45
Investors
Press releases
Weekly report treasury shares buy-back
13/04/18 - 20:30
Investors
Press releases
Weekly report treasury shares buy-back
19/04/18 - 21:00
Investors
Press releases
Weekly report treasury shares buy-back
11/05/18 - 20:15
Investors
Press releases
Weekly report treasury shares buy-back
19/05/18 - 1:45
Investors
Press releases
Weekly report treasury shares buy-back
25/05/18 - 22:30
Investors
Press releases
Weekly report treasury shares buy-back
01/06/18 - 20:15
Investors
Press releases
Weekly report treasury shares buy-back
08/06/18 - 23:15
Investors
Press releases
Weekly report treasury shares buy-back
15/06/18 - 21:00
Investors
Press releases
Weekly report treasury shares buy-back
22/06/18 - 20:30
Investors
Press releases
Weekly report treasury shares buy-back
29/06/18 - 18:15
Investors
Press releases
Weekly report treasury shares buy-back
20/05/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
27/05/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
03/06/16 - 2:00
Investors
Press releases
Weekly report treasury shares buy-back
10/06/16 - 2:00
Investors
Pagination
- First page
- 1
- 2